XIX
Scientific Programme Plenary Lectures Saturday, June 26th, 2010 09.45–10.30
• Eating oneself for immunity and tolerance: the role of autophagy in the immune system Ludger Klein, Munich, Germany
Sunday, June 27th, 2010 09.45–10.30
• Ciliopathy: from bench to bedside Gerd Walz, Freiburg, Germany
09.45–10.30
• Approaches to and biomarkers of transplantation tolerance Robert Lechler, London, UK
Free Communications & Mini Lectures Saturday, June 26th, 2010 08.00–09.30
• Biomarkers and progression 1 Mini Lecture Sex differences for chronic kidney disease: a platform for treatment strategies? Jesus Carrero, Stockholm, Sweden 5 Free Communications
08.00–09.30
• Immune and inflammatory mechanisms Mini Lecture The role of immunoproteasome in the pathogenesis of IgA nephropathy Alessandro Amore, Turin, Italy 5 Free Communications
08.00–09.30
• Transplantation – clinical research 1 Mini Lecture Subclinical rejection: to treat or not? Johan de Fijter, Leiden, Netherlands 5 Free Communications
11.15–12.45
• Acute kidney injury – basic research Mini Lecture Innate immune responses in ischemia/reperfusion injury Sandrine Florquin, Amsterdam, Netherlands 5 Free Communications
11.15–12.45
• Cell signalling Mini Lecture Notch receptors in glomerulonephritis Peter Mertens, Magdeburg, Germany 5 Free Communications
11.15–12.45
• Epidemiology and outcome research 1 6 Free Communications
Downloaded from http://ckj.oxfordjournals.org/ at Oakland University on June 9, 2015
Monday, June 28th, 2010
XX
Sunday, June 27th, 2010
14.45–16.15
Scientific Programme
• Acid base and ions transport 6 Free Communications
14.45–16.15
• Pathophysiology of kidney disease Mini Lecture Suppressors of cytokine signaling (SOCS) and kidney diseases: a potential novel therapeutic target Jesus Egido, Madrid, Spain 5 Free Communications
14.45–16.15
• Cardiovascular diseases 1 Mini Lecture Treatment of hypertension in dialysis patients Olof Heimbürger, Stockholm, Sweden 5 Free Communications
17.00–18.30
5 Free Communications 17.00–18.30
• Glomerular diseases 1 6 Free Communications
17.00–18.30
• Experimental pathology and renal histopathology Mini Lecture Proteinuria triggers immune responses Ariela Benigni, Bergamo, Italy 5 Free Communications
Sunday, June 27th, 2010 08.00–09.30
• Glomerular diseases 2 Mini Lecture Novel treatments for ANCA-associated vasculitis Caroline Savage, Birmingham, UK 5 Free Communications
08.00–09.30
• Diabetes – basic research Mini Lecture Inflammation and proteinuria in diabetic patients Mahmut Ilker Yilmaz, Ankara, Turkey 5 Free Communications
08.00–09.30
• Haemodialysis Mini Lecture How to assess extracellular volume and “dry weight” in dialysis patients – is bioimpedance the answer? Adrian Covic, Iasi, Romania 5 Free Communications
11.30–12.30
• Inflammation and protein-energy wasting 4 Free Communications
11.30–12.30
• Transplantation – clinical research 2 Mini Lecture Transplantation in children with primary hyperoxaluria Dirk E. Mueller-Wiefel, Hamburg, Germany 3 Free Communications
Downloaded from http://ckj.oxfordjournals.org/ at Oakland University on June 9, 2015
• CKD-related bone disease Mini Lecture CKD-related mineral and bone disorders Angel Argilés, Montpellier, France
Scientific Programme 11.30–12.30
Monday, June 28th, 2010
XXI
• Vascular physiology, hormones and hypertension 1 Mini Lecture Blood pressure measurement in CKD Rajiv Agarwal, Indianapolis, USA 3 Free Communications
11.30–12.30
• Peritoneal dialysis 5 Free Communications
14.30–16.00
• Acute kidney injury – clinical research Mini Lecture Standard versus intensified dialysis in AKI in intensive care units Danilo Fliser, Homburg/Saar, Germany 5 Free Communications
14.30–16.00
5 Free Communications 14.30–16.00
• Genetics and renal development 6 Free Communications
14.30–16.00
• Transplantation – basic research Mini Lecture Interplay between ischemia/reperfusion injury and alloreactivity Juan Torras, Barcelona, Spain 5 Free Communications
16.45–18.15
• Anaemia and ESA treatment 6 Free Communications
16.45–18.15
• Predictors and biomarkers based intervention Mini Lecture Body mass index and mortality in dialysis population Renée de Mutsert, Leiden, Netherlands 5 Free Communications
16.45–18.15
• Paediatric nephrology Mini Lecture Chronic dialysis since the first month of life: long-term results Pierre Cochat, Lyon, France 5 Free Communications
Monday, June 28th, 2010 08.00–09.30
• Diabetes – clinical research Mini Lecture Lipid profile and renal function in type 1 diabetes Nina Tolonen, Helsinki, Finland 5 Free Communications
08.00–09.30
• Transplantation – clinical research 3 Mini Lecture Optimal preservation for extended criteria kidneys Rutger Ploeg, Groningen, The Netherlands 5 Free Communications
Downloaded from http://ckj.oxfordjournals.org/ at Oakland University on June 9, 2015
• Cardiovascular diseases 2 Mini Lecture The metabolic syndrome in hypertension Josep Redon, Valencia, Spain
XXII
Saturday, June 26th, 2010
08.00–09.30
Scientific Programme
• Vascular physiology, hormones and hypertension 2 Mini Lecture The dynamic of PTH secretion in response to calcium; the effect of calcimimetics Mariano Rodríguez, Córdoba, Spain 5 Free Communications
11.30–12.30
• Cardiovascular diseases 3 Mini Lecture Sleep disorders in renal patients Francesca Mallamaci, Reggio Calabria, Italy 3 Free Communications
11.30–12.30
• Vascular access 5 Free Communications
11.30–12.30
3 Free Communications
Symposia Saturday, June 26th, 2010 08.00–09.30
• Podocytes – Podocytes – an outside view of the glomerulus Agnes Fogo, Nashville, USA – Podocytes regeneration Paola Romagnani, Florence, Italy – The role of parietal cells in health and disease Marcus J. Moeller, Aachen, Germany – Transcription factors as therapeutic targets in podocytes Peter Mathieson, Bristol, UK
08.00–09.30
• Pathophysiology of AKI – Hypoxia and renal injury Michael S. Wiesener, Erlangen, Germany – TWEAK/FN14 in acute kidney injury Alberto Ortiz, Madrid, Spain – Inflammatory mechanisms in AKI Marc De Broe, Antwerp, Belgium – Monocytes derived cells in acute kidney injury Jeremy Hughes, Edinburg, UK
08.00–09.30
• ERA-EDTA Registry – EVEREST – factors affecting RRT incidence and treatment modality choice Fergus Caskey, Bristol, UK – EVEREST – factors affecting patient survival Anneke Kramer, Amsterdam, The Netherlands – Haemodialysis-Peritoneal dialysis comparisons Moniek van de Luijtgaarden, Amsterdam, The Netherlands – Trends in access to transplantation Vianda Stel, Amsterdam, The Netherlands – The complementary use of Registry data for research into rare diseases Cristoph Wanner, Würzburg, Germany
Downloaded from http://ckj.oxfordjournals.org/ at Oakland University on June 9, 2015
• Epidemiology and outcome research 2 Mini Lecture The year after – How do KDIGO CKD-MBD guidelines impact on clinical practice? Markus Ketteler, Coburg, Germany
Scientific Programme
Saturday, June 26th, 2010
XXIII
• Nephrolithiasis and nephrocalcinosis – Nephrocalcinosis: new insights into mechanisms and consequences Benjamin A. Vervaet, Antwerp, Belgium – Calcium receptors in mineral ion transport Giuseppe Vezzoli, Rome, Italy – Management of hypercalciuria Andrew Schwaderer, Ohio, USA – Non-drug induced nephrotoxicity Justine Bacchetta, Bron, France
11.15–12.45
• Focal segmental glomerulosclerosis – Advanced glycation end-products in diabetic nephropathy: aspects in podocyte pathology C. Rüster, Jena, Germany – Cardiotrophin-like cytokine-1, potential FSGS permeability factor Virginia J. Savin, Milwaukee, USA – Discovery of MYH9 genetic variations and advanced focal segmental glomerular sclerosis Rulan S. Parekh, Toronto, Canada – Update on the treatment of idiopathic FSGS Alain Meyrier, Paris, France
11.15–12.45
• Peritoneal dialysis 1 – Dynamic interactions between peritoneum and abdominal adipocytes: the effect of peritoneal dialysis solutions Daniel Teta, Lausanne, Switzerland – Peritoneal functional pathology: the role of immunohistochemistry in the understanding of peritoneal pathophysiology José Jiménez-Heffernan, Madrid, Spain – Pathophysiology of the peritoneal interstitium and mesothelial cells in ultrafiltration failure (UFF) Bengt Rippe, Lund, Sweden – Biomarkers in peritoneal dialysis Raymond T. Krediet, Amsterdam, Netherlands
11.15–12.45
• Cardiovascular risk biomarkers – Biomarkers: when is it justified to incorporate a new biomarker into clinical practice? Carmine Zoccali, Reggio Calabria, Italy – Inflammation in chronic kidney disease. Etiology, prognosis and treatment Peter Stenvinkel, Stockholm, Sweden – Cardiac natriuretic peptides and risk stratification in CKD Christiane Drechsler, Würzburg, Germany – Cardiovascular risk biomarkers in renal transplantation Didier Ducloux, Besançon, France
11.15–12.45
• KDIGO Symposium: guidelines in AKI – KDIGO Guidelines in acute kidney injury (AKI) Norbert Lameire, Ghent, Belgium – Report on KDIGO Controversies Conference on CKD: Definition, Classification and Prognosis R. Gansevoort, Groningen, Sweden – Report on KDIGO Controversies Conference on Drug Prescribing in Kidney Disease P. Murray, Dublin, Ireland
11.15–12.45
• Protein bound uremic toxins – Metabolism Raymond Vanholder, Gent, Belgium – Protein bound uremic toxins Joachim Jankowski, Berlin, Germany – Removal of protein bound toxins by haemodialysis Horst-Dieter Lemke, Obernburg, Germany – New insights from clinical studies Ziad Massy, Amiens, France
Downloaded from http://ckj.oxfordjournals.org/ at Oakland University on June 9, 2015
08.00–09.30
XXIV
Saturday, June 26th, 2010
Scientific Programme
• Renal transplantation: Clinical pharmacology – Impact of pharmacogenetic testing on dosing of immunosuppressive drugs Teunis van Gelder, Rotterdam, Netherlands – Optimization of immunosuppressants dosing in renal transplantation Yannick Le Meur, Brest, France – Genome wide analysis and transplantation: what is it and what could it bring us? Dirk R. Kuypers, Louvain, Belgium – Population pharmacokinetics in renal transplantation Manuel Oriol, Lausanne, Switzerland
14.45–16.15
• The bone (adipocyte) vascular axis – Klotho, FGF23 and vitamin D: a bone-kidney story and much more Gérard Friedlander, Paris, France – Beyond Ca/P/PTH: clinical evidence of a link between the adipose tissue and bone disease in ESRD Andrzej Wiecek, Katowice, Poland – Vascular calcifications as a risk factor for cardiovascular mortality Leon Schurgers, Maastricht, Netherlands – Vascular calcification: can we control progression and regression? Jorge B. Cannata-Andía, Oviedo, Spain
14.45–16.15
• Cell-driven renal repair – Stem cells and renal regeneration Uta Kunter, Aachen, Germany – Mesenchymal stem cells in organ transplantation Federica Casiraghi, Bergamo, Italy – Potential repairing process of renal progenitor cells in tubular damage Francesco Paolo Schena, Bari, Italy – Stem cells and whole organ scaffolds: implications for kidney regenerative medicine Edward A. Ross, Gainesville, USA
14.45–16.15
• IgA nephropathy – Oxidative stress modulates the nephrotoxicity of aberrantly glycosylated IgA1 Rosanna Coppo, Turin, Italy – C4d deposition in IgA nephropathy Mario Espinosa, Córdoba, Spain – Renal biopsy in IgA nephropathy: the Oxford classification and beyond Ian Roberts, Oxford, UK – IgA nephropathy: a review of recent and ongoing treatment studies Claudio Pozzi, Cinisello Balsamo, Italy
14.45–16.15
• Haemodialysis – Biocompatibility and genomics in dialysis Rainer Oberbauer, Linz, Austria – Hemodialysis-induced release of hemoglobin limits nitric oxide bioavailability and impairs vascular function Tienush Rassaf, Düsseldorf, Germany – Impact of a haemodialysis session for myocardial perfusion Christoph W. McIntyre, Derby, UK – Arrhythmias in dialysis patients Walter H. Hörl, Vienna, Austria
14.45–16.15
• Role of physical fitness in CKD patients – Physical fitness – an integral part of comprehensive care of CKD patients Rolfdieter Krause, Berlin, Germany – The effects of exercise training on muscle with special reference to patients with CKD Tom Mercer, Edinburgh, UK – The impact of physical fitness on morbidity and quality of life in patients with CKD Kirsten Anding-Rost, Bischofswerda, Germany
Downloaded from http://ckj.oxfordjournals.org/ at Oakland University on June 9, 2015
14.45–16.15
Scientific Programme
Sunday, June 27th, 2010
XXV
• European Cardiovascular and Renal Medicine (EURECAM) – EURECAM mission and results of surveys Carmine Zoccali, Reggio Calabria, Italy – The potential of Registries for scientific research in Cardiovascular and Renal Medicine Friedo W. Dekker, Leiden, The Netherlands – Information provided by 24 h ambulatory blood pressure monitoring Gianfranco Parati, Milan, Italy – Potential and caveats on the use of Clinical Trials data-bases for secondary analyses in Cardiovascular and Renal Medicine Johannes Mann, Munich, Germany
17.00–18.30
• Hypertension – Aldosterone-receptor antagonism in hypertension: where do we stand Anton H. van den Meiracker, Rotterdam, The Netherlands – Is aldosterone toxic for renal cells? Eric Féraille, Geneva, Switzerland – Arterial stiffness in renal transplant recipients Francis Verbeke, Ghent, Belgium – Can we treat arterial stiffness? Stéphane Laurent, Paris, France
17.00–18.30
• ERA-EDTA NephroQUEST Working Group – NephroQUEST – different tools to improve the quality of RRT care K. J. Jager, Amsterdam, The Netherlands – Extracting data from electronic patient records C. Jacquelinet, Paris, France – Tools to capture, assess and transfer data to the registry R. Cornet, Amsterdam, The Netherlands – Collection of clinical performance indicators: a new registry experience J. Buturovic-Ponikvar, Ljubljana, Slovenia – The new ESPN/ERA-EDTA Registry for paediatric patients K. van Stralen, Amsterdam, The Netherlands – Data quality in registries C. Couchoud, Paris, France – Development of state-of-the-art reporting to centres G. von Gersdorff, Cologne, Germany – Implementing quality improvement in RRT: the role of registries S. van der Veer, Amsterdam, The Netherlands
Sunday, June 27th, 2010 08.00–09.30
• Renal transplantation: the humoral barrier – ABO incompatible renal transplantation Marcel Geyer, Freiburg, Germany – Prevention and treatment of antibody-mediated rejection Denis Glotz, Paris, France – The role of costimulatory signals in antibody-mediated rejection Suzanne T. Ildstad, Louisville, USA – Novel therapies to inhibit humoral responses: the role of proteosome inhibition Flavio Vincenti, San Francisco, USA
08.00–09.30
• Is cardiorenal syndrome a new entity? – Pro Claudio Ronco, Vicenza, Italy – Con Walter H. Hörl, Vienna, Austria – Impact of various manifestations of renal dysfunction on heart failure Gerjan Navis, Groningen, The Netherlands – Continuous extracorporeal treatments in heart failure Giancarlo Marenzi, Milan, Italy
Downloaded from http://ckj.oxfordjournals.org/ at Oakland University on June 9, 2015
17.00–18.30
XXVI
Sunday, June 27th, 2010
Scientific Programme
• Renal physiology – Renal and extrarenal effects of Klotho Florian Lang, Tübingen, Germany – Novel genetic disorders of nephron function Robert Kleta, London, UK – Novel aspects of the renin-angiotensin-system Armin Kurtz, Regensburg, Germany – Novel aspects of sodium resorption and storage Jens Titze, Erlangen, Germany
11.30–12.30
• Outcomes in renal transplantation – Current impact of HLA compatibility and immunosuppression on graft survival Gerhard Opelz, Heidelberg, Germany – Long-term outcomes of the European Senior Program Urlich Frei, Berlin, Germany – Sustained improvement of graft survival: is it feasible? Josep M. Campistol, Barcelona, Spain
11.30–12.30
• Sympathetic overactivity in hypertension and in CKD – The pathogenesis and clinical relevance of sympathetic hyperactivity in chronic kidney disease Peter J. Blankestijn, Utrecht, Netherlands – Pharmacologic interference with the sympathetic system in cardiovascular and renal diseases Guido Grassi, Monza, Italy – Renal sympathetic denervation in resistant hypertension in humans Henry Krum, Melbourne, Australia
11.30–12.30
• New insights into rare CKD-associated diseases – Calciphylaxis Vincent Brandenburg, Aachen, Germany – Encapsulating peritoneal sclerosis Angela M. Summers, Manchester, UK – Nephrogenic systemic fibrosis Andreas Kribben, Essen, Germany
11.30–12.30
• Immune mechanisms in autoimmune nephritis – Pseudoviral immunity. The novel concept of lupus nephritis Hans Joachim Anders, Munich, Germany – The TH1 and TH17 immune response in glomerulonephritis Oliver Steinmetz, Hamburg, Germany – Novel roles of chemokines Carla Zoja, Bergamo, Italy
11.30–12.30
• When to start dialysis – Ideal time for starting renal replacement therapy Friedo W. Dekker, Leiden, Netherlands – Unplanned start on assisted peritoneal dialysis Johan Vestergaard Povlsen, Aarhus, Denmark – Which role for incremental peritoneal dialysis Giusto Viglino, Alba, Italy
14.30–16.00
• Progression of renal damage – Controlling transglutaminase type 2 prevents the progression of chronic kidney disease Timothy S. Johnson, Sheffield, UK – Capillary rarefication, angiogenesis and VEGF in the progression of renal disease Gert Mayer, Innsbruck, Austria – Danger-associated molecular pattern (DAMP) molecules in progressive renal disease Detlef O. Schlöndorff, New York, USA – Growth factors in renal regeneration Josep M. Cruzado, Barcelona, Spain
Downloaded from http://ckj.oxfordjournals.org/ at Oakland University on June 9, 2015
08.00–09.30
Scientific Programme
Monday, June 28th, 2010
XXVII
• KDIGO on management of glomerular diseases – Introduction John Feehally, Leicester, UK – Treatment of Minimal change nephropathy and FSGS Jack S.M. Wetzels, Nijmegen, The Netherlands – IgA nephropathy Jürgen Floege, Aachen, Germany – Membranous and membranoproliferative glomerulonephritis Vivekanand Jha, Chandigarh, India – Lupus and vasculitis Fernando Fervenza, Rochester, USA
14.30–16.00
• Peritoneal dialysis 2 – Multicenter experience with low-sodium peritoneal dialysis solutions Simon Davies, Stoke-on-Trent, UK – Financial aspects in peritoneal dialysis J. Chanliau, Vandoeuvre Les Nancy, France – Current outcomes in peritoneal dialysis Giovanni Cancarini, Brescia, Italy
16.45–18.15
• Prevention of cardiovascular risk in renal patients – Nutritional initiatives to decrease cardiovascular risk in CKD Michal Chmielewski, Gdansk, Poland – Limitations of statins in the prevention of cardiovascular events in dialysis patients Bengt Fellstrom, Uppsala, Sweden – Effect of blood pressure lowering on cardiovascular morbidity and mortality in people with chronic kidney disease Hiddo J. Lambers Heerspink, Groningen, The Netherlands – Atherosclerosis and vascular calcification and CKD – Insights from animal models Ziad A. Massy, Amiens, France
16.45–18.15
• Transplantation: New immunosuppressants – Jak-3 inhibitors Willem Weimar, Rotterdam, Netherlands – Costimulatory signal blockers Thomas Wekerle, Vienna, Austria – Is there a role for new anti-B cells and anti-complement agents in kidney transplant patients? Lionel Rostaing, Toulouse, France – Novel therapies to inhibit adhesion and coactivation pathways Flavio Vincenti, San Francisco, USA
16.45–18.15
• Ciliopathies – Signaling pathways and function of primary cilia Søren Tvorup Christensen, Copenhagen, Denmark – The dynamic cilium in human diseases: the example of the OFDI syndrome Brunella Franco, Naples, Italy – How animal models for PKD mimic human disease Albert Ong, Sheffield, UK – Restoration of renal function in animal models of ciliopathies Jonathan L. Tobin, London, UK
16.45–18.15
• Immunonephrology – Organization and activities of the Immunonephrology Working Group Mohamed R. Daha, Leiden, The Netherlands – Proposal from the group: validation study of the clinico-pathological classification of IgAN in Europe Rosanna Coppo, Turin, Italy – Proposals of new collaborative studies on rare diseases and recurrent glomerular diseases after transplantation Jürgen Floege, Aachen, Germany – Scientific fair: an opportunity to increase networking Loreto Gesualdo, Foggia, Italy
Downloaded from http://ckj.oxfordjournals.org/ at Oakland University on June 9, 2015
14.30–16.00
XXVIII
Monday, June 28th, 2010
Scientific Programme
Monday, June 28th, 2010 • T regulatory cells in renal transplantation – T regulatory cells in alloimmune response Kathryn Wood, Oxford, UK – Mastering Treg function to promote tolerance Angus W. Thomson, Pittsburgh, USA – Adoptive cell therapy with regulatory T cells in renal transplantation Giovanna Lombardi, London, UK – Intragraft T regulatory cells in kidney transplantation Oriol Bestard, Barcelona, Spain
08.00–09.30
• ERBP – ERBP as the current guidance body of European nephrology: current status Raymond Vanholder, Ghent, Belgium – ERBP position statement on dialysis membrane flux James Tattersall, Leeds, UK – ERBP position statement on the KDIGO CKD-MBD guidelines Gérard London, Fleury-Mérogis, France – ERBP position statement on prevention and treatment of central vein hemodialysis catheters Raymond Vanholder, Ghent, Belgium – ERBP advice on testing of peritoneal membrane quality Wim Van Biesen, Ghent, Belgium
08.00–09.30
• Treatment of glomerular diseases – Multitarget therapy for lupus nephritis David Jayne, Cambridge, UK – Current therapies in membranous nephropathy José Ballarin, Barcelona, Spain – Outcomes of recent trials in ANCA-associated vasculitis Kirsten de Groot, Offenbach, Germany – Complement regulation and haemolytic uremic syndrome David Kavanagh, Newcastle, UK
08.00–09.30
• Anaemia in CKD – Haemoglobin variability in non-dialysis CKD patients A.L.M de Francisco, Santander, Spain – Hepcidin levels and erythropoietin response in CKD patients Damien R. Ashby, London, UK – Modifying iron balance in CKD patients, is BMP signalling a reasonable target? Donal Reddan, Galway, Ireland – Anaemia management in patients with CKD: European Best Practice recommendations Francesco Locatelli, Lecco, Italy
08.00–09.30
• Tubular transport – Calcium in motion: from renal transporters to new concepts René Bindels, Nijmegen, The Netherlands – Distal tubular potassium channels and renal salt wasting Richard Warth, Regensburg, Germany – The epithelial sodium channel (ENaC) and its role in arterial hypertension and renal sodium retention Cristoph Korbmacher, Erlangen, Germany – Amino acid transport François Verrey, Zürich, Switzerland
11.30–12.30
• Endothelin and endothelin-receptor antagonists – Pathophysiology of the endothelin system: lessons from genetically manipulated animals models Berthold Hocher, Berlin, Germany – Endothelin-1 and its antagonism in chronic kidney disease Neeraj Dhaun, Edinburgh, UK – Endothelin receptor antagonists in diabetic nephropathy René R. Wenzel, Zell am See, Austria
Downloaded from http://ckj.oxfordjournals.org/ at Oakland University on June 9, 2015
08.00–09.30
Scientific Programme
Sunday, June 27th, 2010
• The bone and CKD – The culprit of osteoporosis in CKD Marie-Hélène Lafage-Proust, Saint-Etienne, France – Calcium metabolism changes after transplantation Pieter Evenepoel, Leuven, Belgium – Adynamic bone disease: from bone to vessels Jordi Bover, Barcelona, Spain
11.30–12.30
• Nephroprotection – Screening for albuminuria in the prevention of renal function loss Ronald T. Gansevoort, Groningen, Netherlands – RAAS blockade in native and grafted kidneys P. Rutkowski, Gdansk, Poland – Pleiotropic effects of ATR1 blockers Giuseppe Remuzzi, Bergamo, Italy
11.30–12.30
• Regulatory aspects of kidney function – (Patho)physiology of intercalated cells Carsten Wagner, Zürich, Switzerland – The serum and glucocorticoid inducible kinase SGK1 in the regulation of renal function and blood pressure Florian Lang, Tübingen, Germany – Impact of trans- and paracellular permeability Markus Bleich, Kiel, Germany
Literature Updates Saturday, June 26th, 2010 17.00–18.30
• Clinical nephrology – Optimal management of hypertension Giuseppe Mancia, Milan, Italy – Side effects in treatment in nephrology David Jayne, Cambridge, UK – Current and future therapy of glomerular diseases Alan Salama, London, UK
17.00–18.30
• Transplantation – What should we be doing about renal preservation? N. Mamode, London, UK – Immunosuppression Uwe Heemann, Munich, Germany – Polyomavirus infection in renal transplantation Cristina Costa, Turin, Italy – Recurrent renal diseases Pierre Cochat, Lyon, France
Sunday, June 27th, 2010 16.45–18.15
• Dialysis – Fluid balance and core temperature control to improve hemodynamic stability Karel Leunissen, Maastricht, Netherlands – Diffusive and convective toxin removal by dialysis procedures Detlef Krieter, Würzburg, Germany – Vaccination and hygiene strategies for infection prevention Michel Jadoul, Louvain, Belgium – Oxidative stress in dialysis patients: causes and consequences Jan Kielstein, Hannover, Germany
Downloaded from http://ckj.oxfordjournals.org/ at Oakland University on June 9, 2015
11.30–12.30
XXIX
XXX
Sunday, June 27th, 2010
Scientific Programme
Compact Primers Sunday, June 27th, 2010 • Treatment of AKI in special populations – Renal transplantation Christophe Legendre, Paris, France – AKI in children Franz Schaefer, Heidelberg, Germany – AKI in HIV-infected patients Paul L. Kimmel, Bethesda, USA – Treatment of AKI in oncology patients Claudio Ronco, Vicenza, Italy
14.30–16.00
• Practices in renal transplantation – Cardiovascular screening of potential transplant recipients Alan G. Jardine, Glasgow, UK – Sense or non sense of screening transplant recipients for malignancies Bryce Kiberd, Halifax, Canada – Pregnancy in transplant donors Anna Varberg Reisaeter, Oslo, Norway – Donor registries: the common Living Donor Database within Scandinavia Ole Oyen, Oslo, Norway
Monday, June 28th, 2010 11.30–12.30
• Peritoneal dialysis in special patients – Volume in PD: the heart of the matter Wim van Biesen, Ghent, Belgium – Peritoneal dialysis in cirrhotic patients: effects on portal hypertension Rafael Selgas, Madrid, Spain – Optimal use of peritoneal dialyis in diabetic patients Francisco Coronel, Madrid, Spain
Pre-Congress CME Courses Friday, June 25th, 2010 08.00–12.30
13.00–17.30
• Animal models of renal diseases • Transplant immunology • Renal ultrasonography • Omics in nephrology • Rheumatology for nephrologists
Sunday, June 27th, 2010 16.45–18.15
• Rare renal diseases
Late Breaking Trials Saturday, June 26th, 2010 08.00–09.30
• Late breaking trials 1
Sunday, June 27th, 2010 14.30–16.00
• Late breaking trials 2
Downloaded from http://ckj.oxfordjournals.org/ at Oakland University on June 9, 2015
08.00–09.30
Scientific Programme Plenary Lectures Saturday, June 26th, 2010 09.45–10.30
• Eating oneself for immunity and tolerance: the role of autophagy in the immune system Ludger Klein, Munich, Germany
Sunday, June 27th, 2010 09.45–10.30
• Ciliopathy: from bench to bedside Gerd Walz, Freiburg, Germany
09.45–10.30
• Approaches to and biomarkers of transplantation tolerance Robert Lechler, London, UK
Free Communications & Mini Lectures Saturday, June 26th, 2010 08.00–09.30
• Biomarkers and progression 1 Mini Lecture Sex differences for chronic kidney disease: a platform for treatment strategies? Jesus Carrero, Stockholm, Sweden 5 Free Communications
08.00–09.30
• Immune and inflammatory mechanisms Mini Lecture The role of immunoproteasome in the pathogenesis of IgA nephropathy Alessandro Amore, Turin, Italy 5 Free Communications
08.00–09.30
• Transplantation – clinical research 1 Mini Lecture Subclinical rejection: to treat or not? Johan de Fijter, Leiden, Netherlands 5 Free Communications
11.15–12.45
• Acute kidney injury – basic research Mini Lecture Innate immune responses in ischemia/reperfusion injury Sandrine Florquin, Amsterdam, Netherlands 5 Free Communications
11.15–12.45
• Cell signalling Mini Lecture Notch receptors in glomerulonephritis Peter Mertens, Magdeburg, Germany 5 Free Communications
11.15–12.45
• Epidemiology and outcome research 1 6 Free Communications
Downloaded from http://ckj.oxfordjournals.org/ at Oakland University on June 9, 2015
Monday, June 28th, 2010
XX
Sunday, June 27th, 2010
14.45–16.15
Scientific Programme
• Acid base and ions transport 6 Free Communications
14.45–16.15
• Pathophysiology of kidney disease Mini Lecture Suppressors of cytokine signaling (SOCS) and kidney diseases: a potential novel therapeutic target Jesus Egido, Madrid, Spain 5 Free Communications
14.45–16.15
• Cardiovascular diseases 1 Mini Lecture Treatment of hypertension in dialysis patients Olof Heimbürger, Stockholm, Sweden 5 Free Communications
17.00–18.30
5 Free Communications 17.00–18.30
• Glomerular diseases 1 6 Free Communications
17.00–18.30
• Experimental pathology and renal histopathology Mini Lecture Proteinuria triggers immune responses Ariela Benigni, Bergamo, Italy 5 Free Communications
Sunday, June 27th, 2010 08.00–09.30
• Glomerular diseases 2 Mini Lecture Novel treatments for ANCA-associated vasculitis Caroline Savage, Birmingham, UK 5 Free Communications
08.00–09.30
• Diabetes – basic research Mini Lecture Inflammation and proteinuria in diabetic patients Mahmut Ilker Yilmaz, Ankara, Turkey 5 Free Communications
08.00–09.30
• Haemodialysis Mini Lecture How to assess extracellular volume and “dry weight” in dialysis patients – is bioimpedance the answer? Adrian Covic, Iasi, Romania 5 Free Communications
11.30–12.30
• Inflammation and protein-energy wasting 4 Free Communications
11.30–12.30
• Transplantation – clinical research 2 Mini Lecture Transplantation in children with primary hyperoxaluria Dirk E. Mueller-Wiefel, Hamburg, Germany 3 Free Communications
Downloaded from http://ckj.oxfordjournals.org/ at Oakland University on June 9, 2015
• CKD-related bone disease Mini Lecture CKD-related mineral and bone disorders Angel Argilés, Montpellier, France
Scientific Programme 11.30–12.30
Monday, June 28th, 2010
XXI
• Vascular physiology, hormones and hypertension 1 Mini Lecture Blood pressure measurement in CKD Rajiv Agarwal, Indianapolis, USA 3 Free Communications
11.30–12.30
• Peritoneal dialysis 5 Free Communications
14.30–16.00
• Acute kidney injury – clinical research Mini Lecture Standard versus intensified dialysis in AKI in intensive care units Danilo Fliser, Homburg/Saar, Germany 5 Free Communications
14.30–16.00
5 Free Communications 14.30–16.00
• Genetics and renal development 6 Free Communications
14.30–16.00
• Transplantation – basic research Mini Lecture Interplay between ischemia/reperfusion injury and alloreactivity Juan Torras, Barcelona, Spain 5 Free Communications
16.45–18.15
• Anaemia and ESA treatment 6 Free Communications
16.45–18.15
• Predictors and biomarkers based intervention Mini Lecture Body mass index and mortality in dialysis population Renée de Mutsert, Leiden, Netherlands 5 Free Communications
16.45–18.15
• Paediatric nephrology Mini Lecture Chronic dialysis since the first month of life: long-term results Pierre Cochat, Lyon, France 5 Free Communications
Monday, June 28th, 2010 08.00–09.30
• Diabetes – clinical research Mini Lecture Lipid profile and renal function in type 1 diabetes Nina Tolonen, Helsinki, Finland 5 Free Communications
08.00–09.30
• Transplantation – clinical research 3 Mini Lecture Optimal preservation for extended criteria kidneys Rutger Ploeg, Groningen, The Netherlands 5 Free Communications
Downloaded from http://ckj.oxfordjournals.org/ at Oakland University on June 9, 2015
• Cardiovascular diseases 2 Mini Lecture The metabolic syndrome in hypertension Josep Redon, Valencia, Spain
XXII
Saturday, June 26th, 2010
08.00–09.30
Scientific Programme
• Vascular physiology, hormones and hypertension 2 Mini Lecture The dynamic of PTH secretion in response to calcium; the effect of calcimimetics Mariano Rodríguez, Córdoba, Spain 5 Free Communications
11.30–12.30
• Cardiovascular diseases 3 Mini Lecture Sleep disorders in renal patients Francesca Mallamaci, Reggio Calabria, Italy 3 Free Communications
11.30–12.30
• Vascular access 5 Free Communications
11.30–12.30
3 Free Communications
Symposia Saturday, June 26th, 2010 08.00–09.30
• Podocytes – Podocytes – an outside view of the glomerulus Agnes Fogo, Nashville, USA – Podocytes regeneration Paola Romagnani, Florence, Italy – The role of parietal cells in health and disease Marcus J. Moeller, Aachen, Germany – Transcription factors as therapeutic targets in podocytes Peter Mathieson, Bristol, UK
08.00–09.30
• Pathophysiology of AKI – Hypoxia and renal injury Michael S. Wiesener, Erlangen, Germany – TWEAK/FN14 in acute kidney injury Alberto Ortiz, Madrid, Spain – Inflammatory mechanisms in AKI Marc De Broe, Antwerp, Belgium – Monocytes derived cells in acute kidney injury Jeremy Hughes, Edinburg, UK
08.00–09.30
• ERA-EDTA Registry – EVEREST – factors affecting RRT incidence and treatment modality choice Fergus Caskey, Bristol, UK – EVEREST – factors affecting patient survival Anneke Kramer, Amsterdam, The Netherlands – Haemodialysis-Peritoneal dialysis comparisons Moniek van de Luijtgaarden, Amsterdam, The Netherlands – Trends in access to transplantation Vianda Stel, Amsterdam, The Netherlands – The complementary use of Registry data for research into rare diseases Cristoph Wanner, Würzburg, Germany
Downloaded from http://ckj.oxfordjournals.org/ at Oakland University on June 9, 2015
• Epidemiology and outcome research 2 Mini Lecture The year after – How do KDIGO CKD-MBD guidelines impact on clinical practice? Markus Ketteler, Coburg, Germany
Scientific Programme
Saturday, June 26th, 2010
XXIII
• Nephrolithiasis and nephrocalcinosis – Nephrocalcinosis: new insights into mechanisms and consequences Benjamin A. Vervaet, Antwerp, Belgium – Calcium receptors in mineral ion transport Giuseppe Vezzoli, Rome, Italy – Management of hypercalciuria Andrew Schwaderer, Ohio, USA – Non-drug induced nephrotoxicity Justine Bacchetta, Bron, France
11.15–12.45
• Focal segmental glomerulosclerosis – Advanced glycation end-products in diabetic nephropathy: aspects in podocyte pathology C. Rüster, Jena, Germany – Cardiotrophin-like cytokine-1, potential FSGS permeability factor Virginia J. Savin, Milwaukee, USA – Discovery of MYH9 genetic variations and advanced focal segmental glomerular sclerosis Rulan S. Parekh, Toronto, Canada – Update on the treatment of idiopathic FSGS Alain Meyrier, Paris, France
11.15–12.45
• Peritoneal dialysis 1 – Dynamic interactions between peritoneum and abdominal adipocytes: the effect of peritoneal dialysis solutions Daniel Teta, Lausanne, Switzerland – Peritoneal functional pathology: the role of immunohistochemistry in the understanding of peritoneal pathophysiology José Jiménez-Heffernan, Madrid, Spain – Pathophysiology of the peritoneal interstitium and mesothelial cells in ultrafiltration failure (UFF) Bengt Rippe, Lund, Sweden – Biomarkers in peritoneal dialysis Raymond T. Krediet, Amsterdam, Netherlands
11.15–12.45
• Cardiovascular risk biomarkers – Biomarkers: when is it justified to incorporate a new biomarker into clinical practice? Carmine Zoccali, Reggio Calabria, Italy – Inflammation in chronic kidney disease. Etiology, prognosis and treatment Peter Stenvinkel, Stockholm, Sweden – Cardiac natriuretic peptides and risk stratification in CKD Christiane Drechsler, Würzburg, Germany – Cardiovascular risk biomarkers in renal transplantation Didier Ducloux, Besançon, France
11.15–12.45
• KDIGO Symposium: guidelines in AKI – KDIGO Guidelines in acute kidney injury (AKI) Norbert Lameire, Ghent, Belgium – Report on KDIGO Controversies Conference on CKD: Definition, Classification and Prognosis R. Gansevoort, Groningen, Sweden – Report on KDIGO Controversies Conference on Drug Prescribing in Kidney Disease P. Murray, Dublin, Ireland
11.15–12.45
• Protein bound uremic toxins – Metabolism Raymond Vanholder, Gent, Belgium – Protein bound uremic toxins Joachim Jankowski, Berlin, Germany – Removal of protein bound toxins by haemodialysis Horst-Dieter Lemke, Obernburg, Germany – New insights from clinical studies Ziad Massy, Amiens, France
Downloaded from http://ckj.oxfordjournals.org/ at Oakland University on June 9, 2015
08.00–09.30
XXIV
Saturday, June 26th, 2010
Scientific Programme
• Renal transplantation: Clinical pharmacology – Impact of pharmacogenetic testing on dosing of immunosuppressive drugs Teunis van Gelder, Rotterdam, Netherlands – Optimization of immunosuppressants dosing in renal transplantation Yannick Le Meur, Brest, France – Genome wide analysis and transplantation: what is it and what could it bring us? Dirk R. Kuypers, Louvain, Belgium – Population pharmacokinetics in renal transplantation Manuel Oriol, Lausanne, Switzerland
14.45–16.15
• The bone (adipocyte) vascular axis – Klotho, FGF23 and vitamin D: a bone-kidney story and much more Gérard Friedlander, Paris, France – Beyond Ca/P/PTH: clinical evidence of a link between the adipose tissue and bone disease in ESRD Andrzej Wiecek, Katowice, Poland – Vascular calcifications as a risk factor for cardiovascular mortality Leon Schurgers, Maastricht, Netherlands – Vascular calcification: can we control progression and regression? Jorge B. Cannata-Andía, Oviedo, Spain
14.45–16.15
• Cell-driven renal repair – Stem cells and renal regeneration Uta Kunter, Aachen, Germany – Mesenchymal stem cells in organ transplantation Federica Casiraghi, Bergamo, Italy – Potential repairing process of renal progenitor cells in tubular damage Francesco Paolo Schena, Bari, Italy – Stem cells and whole organ scaffolds: implications for kidney regenerative medicine Edward A. Ross, Gainesville, USA
14.45–16.15
• IgA nephropathy – Oxidative stress modulates the nephrotoxicity of aberrantly glycosylated IgA1 Rosanna Coppo, Turin, Italy – C4d deposition in IgA nephropathy Mario Espinosa, Córdoba, Spain – Renal biopsy in IgA nephropathy: the Oxford classification and beyond Ian Roberts, Oxford, UK – IgA nephropathy: a review of recent and ongoing treatment studies Claudio Pozzi, Cinisello Balsamo, Italy
14.45–16.15
• Haemodialysis – Biocompatibility and genomics in dialysis Rainer Oberbauer, Linz, Austria – Hemodialysis-induced release of hemoglobin limits nitric oxide bioavailability and impairs vascular function Tienush Rassaf, Düsseldorf, Germany – Impact of a haemodialysis session for myocardial perfusion Christoph W. McIntyre, Derby, UK – Arrhythmias in dialysis patients Walter H. Hörl, Vienna, Austria
14.45–16.15
• Role of physical fitness in CKD patients – Physical fitness – an integral part of comprehensive care of CKD patients Rolfdieter Krause, Berlin, Germany – The effects of exercise training on muscle with special reference to patients with CKD Tom Mercer, Edinburgh, UK – The impact of physical fitness on morbidity and quality of life in patients with CKD Kirsten Anding-Rost, Bischofswerda, Germany
Downloaded from http://ckj.oxfordjournals.org/ at Oakland University on June 9, 2015
14.45–16.15
Scientific Programme
Sunday, June 27th, 2010
XXV
• European Cardiovascular and Renal Medicine (EURECAM) – EURECAM mission and results of surveys Carmine Zoccali, Reggio Calabria, Italy – The potential of Registries for scientific research in Cardiovascular and Renal Medicine Friedo W. Dekker, Leiden, The Netherlands – Information provided by 24 h ambulatory blood pressure monitoring Gianfranco Parati, Milan, Italy – Potential and caveats on the use of Clinical Trials data-bases for secondary analyses in Cardiovascular and Renal Medicine Johannes Mann, Munich, Germany
17.00–18.30
• Hypertension – Aldosterone-receptor antagonism in hypertension: where do we stand Anton H. van den Meiracker, Rotterdam, The Netherlands – Is aldosterone toxic for renal cells? Eric Féraille, Geneva, Switzerland – Arterial stiffness in renal transplant recipients Francis Verbeke, Ghent, Belgium – Can we treat arterial stiffness? Stéphane Laurent, Paris, France
17.00–18.30
• ERA-EDTA NephroQUEST Working Group – NephroQUEST – different tools to improve the quality of RRT care K. J. Jager, Amsterdam, The Netherlands – Extracting data from electronic patient records C. Jacquelinet, Paris, France – Tools to capture, assess and transfer data to the registry R. Cornet, Amsterdam, The Netherlands – Collection of clinical performance indicators: a new registry experience J. Buturovic-Ponikvar, Ljubljana, Slovenia – The new ESPN/ERA-EDTA Registry for paediatric patients K. van Stralen, Amsterdam, The Netherlands – Data quality in registries C. Couchoud, Paris, France – Development of state-of-the-art reporting to centres G. von Gersdorff, Cologne, Germany – Implementing quality improvement in RRT: the role of registries S. van der Veer, Amsterdam, The Netherlands
Sunday, June 27th, 2010 08.00–09.30
• Renal transplantation: the humoral barrier – ABO incompatible renal transplantation Marcel Geyer, Freiburg, Germany – Prevention and treatment of antibody-mediated rejection Denis Glotz, Paris, France – The role of costimulatory signals in antibody-mediated rejection Suzanne T. Ildstad, Louisville, USA – Novel therapies to inhibit humoral responses: the role of proteosome inhibition Flavio Vincenti, San Francisco, USA
08.00–09.30
• Is cardiorenal syndrome a new entity? – Pro Claudio Ronco, Vicenza, Italy – Con Walter H. Hörl, Vienna, Austria – Impact of various manifestations of renal dysfunction on heart failure Gerjan Navis, Groningen, The Netherlands – Continuous extracorporeal treatments in heart failure Giancarlo Marenzi, Milan, Italy
Downloaded from http://ckj.oxfordjournals.org/ at Oakland University on June 9, 2015
17.00–18.30
XXVI
Sunday, June 27th, 2010
Scientific Programme
• Renal physiology – Renal and extrarenal effects of Klotho Florian Lang, Tübingen, Germany – Novel genetic disorders of nephron function Robert Kleta, London, UK – Novel aspects of the renin-angiotensin-system Armin Kurtz, Regensburg, Germany – Novel aspects of sodium resorption and storage Jens Titze, Erlangen, Germany
11.30–12.30
• Outcomes in renal transplantation – Current impact of HLA compatibility and immunosuppression on graft survival Gerhard Opelz, Heidelberg, Germany – Long-term outcomes of the European Senior Program Urlich Frei, Berlin, Germany – Sustained improvement of graft survival: is it feasible? Josep M. Campistol, Barcelona, Spain
11.30–12.30
• Sympathetic overactivity in hypertension and in CKD – The pathogenesis and clinical relevance of sympathetic hyperactivity in chronic kidney disease Peter J. Blankestijn, Utrecht, Netherlands – Pharmacologic interference with the sympathetic system in cardiovascular and renal diseases Guido Grassi, Monza, Italy – Renal sympathetic denervation in resistant hypertension in humans Henry Krum, Melbourne, Australia
11.30–12.30
• New insights into rare CKD-associated diseases – Calciphylaxis Vincent Brandenburg, Aachen, Germany – Encapsulating peritoneal sclerosis Angela M. Summers, Manchester, UK – Nephrogenic systemic fibrosis Andreas Kribben, Essen, Germany
11.30–12.30
• Immune mechanisms in autoimmune nephritis – Pseudoviral immunity. The novel concept of lupus nephritis Hans Joachim Anders, Munich, Germany – The TH1 and TH17 immune response in glomerulonephritis Oliver Steinmetz, Hamburg, Germany – Novel roles of chemokines Carla Zoja, Bergamo, Italy
11.30–12.30
• When to start dialysis – Ideal time for starting renal replacement therapy Friedo W. Dekker, Leiden, Netherlands – Unplanned start on assisted peritoneal dialysis Johan Vestergaard Povlsen, Aarhus, Denmark – Which role for incremental peritoneal dialysis Giusto Viglino, Alba, Italy
14.30–16.00
• Progression of renal damage – Controlling transglutaminase type 2 prevents the progression of chronic kidney disease Timothy S. Johnson, Sheffield, UK – Capillary rarefication, angiogenesis and VEGF in the progression of renal disease Gert Mayer, Innsbruck, Austria – Danger-associated molecular pattern (DAMP) molecules in progressive renal disease Detlef O. Schlöndorff, New York, USA – Growth factors in renal regeneration Josep M. Cruzado, Barcelona, Spain
Downloaded from http://ckj.oxfordjournals.org/ at Oakland University on June 9, 2015
08.00–09.30
Scientific Programme
Monday, June 28th, 2010
XXVII
• KDIGO on management of glomerular diseases – Introduction John Feehally, Leicester, UK – Treatment of Minimal change nephropathy and FSGS Jack S.M. Wetzels, Nijmegen, The Netherlands – IgA nephropathy Jürgen Floege, Aachen, Germany – Membranous and membranoproliferative glomerulonephritis Vivekanand Jha, Chandigarh, India – Lupus and vasculitis Fernando Fervenza, Rochester, USA
14.30–16.00
• Peritoneal dialysis 2 – Multicenter experience with low-sodium peritoneal dialysis solutions Simon Davies, Stoke-on-Trent, UK – Financial aspects in peritoneal dialysis J. Chanliau, Vandoeuvre Les Nancy, France – Current outcomes in peritoneal dialysis Giovanni Cancarini, Brescia, Italy
16.45–18.15
• Prevention of cardiovascular risk in renal patients – Nutritional initiatives to decrease cardiovascular risk in CKD Michal Chmielewski, Gdansk, Poland – Limitations of statins in the prevention of cardiovascular events in dialysis patients Bengt Fellstrom, Uppsala, Sweden – Effect of blood pressure lowering on cardiovascular morbidity and mortality in people with chronic kidney disease Hiddo J. Lambers Heerspink, Groningen, The Netherlands – Atherosclerosis and vascular calcification and CKD – Insights from animal models Ziad A. Massy, Amiens, France
16.45–18.15
• Transplantation: New immunosuppressants – Jak-3 inhibitors Willem Weimar, Rotterdam, Netherlands – Costimulatory signal blockers Thomas Wekerle, Vienna, Austria – Is there a role for new anti-B cells and anti-complement agents in kidney transplant patients? Lionel Rostaing, Toulouse, France – Novel therapies to inhibit adhesion and coactivation pathways Flavio Vincenti, San Francisco, USA
16.45–18.15
• Ciliopathies – Signaling pathways and function of primary cilia Søren Tvorup Christensen, Copenhagen, Denmark – The dynamic cilium in human diseases: the example of the OFDI syndrome Brunella Franco, Naples, Italy – How animal models for PKD mimic human disease Albert Ong, Sheffield, UK – Restoration of renal function in animal models of ciliopathies Jonathan L. Tobin, London, UK
16.45–18.15
• Immunonephrology – Organization and activities of the Immunonephrology Working Group Mohamed R. Daha, Leiden, The Netherlands – Proposal from the group: validation study of the clinico-pathological classification of IgAN in Europe Rosanna Coppo, Turin, Italy – Proposals of new collaborative studies on rare diseases and recurrent glomerular diseases after transplantation Jürgen Floege, Aachen, Germany – Scientific fair: an opportunity to increase networking Loreto Gesualdo, Foggia, Italy
Downloaded from http://ckj.oxfordjournals.org/ at Oakland University on June 9, 2015
14.30–16.00
XXVIII
Monday, June 28th, 2010
Scientific Programme
Monday, June 28th, 2010 • T regulatory cells in renal transplantation – T regulatory cells in alloimmune response Kathryn Wood, Oxford, UK – Mastering Treg function to promote tolerance Angus W. Thomson, Pittsburgh, USA – Adoptive cell therapy with regulatory T cells in renal transplantation Giovanna Lombardi, London, UK – Intragraft T regulatory cells in kidney transplantation Oriol Bestard, Barcelona, Spain
08.00–09.30
• ERBP – ERBP as the current guidance body of European nephrology: current status Raymond Vanholder, Ghent, Belgium – ERBP position statement on dialysis membrane flux James Tattersall, Leeds, UK – ERBP position statement on the KDIGO CKD-MBD guidelines Gérard London, Fleury-Mérogis, France – ERBP position statement on prevention and treatment of central vein hemodialysis catheters Raymond Vanholder, Ghent, Belgium – ERBP advice on testing of peritoneal membrane quality Wim Van Biesen, Ghent, Belgium
08.00–09.30
• Treatment of glomerular diseases – Multitarget therapy for lupus nephritis David Jayne, Cambridge, UK – Current therapies in membranous nephropathy José Ballarin, Barcelona, Spain – Outcomes of recent trials in ANCA-associated vasculitis Kirsten de Groot, Offenbach, Germany – Complement regulation and haemolytic uremic syndrome David Kavanagh, Newcastle, UK
08.00–09.30
• Anaemia in CKD – Haemoglobin variability in non-dialysis CKD patients A.L.M de Francisco, Santander, Spain – Hepcidin levels and erythropoietin response in CKD patients Damien R. Ashby, London, UK – Modifying iron balance in CKD patients, is BMP signalling a reasonable target? Donal Reddan, Galway, Ireland – Anaemia management in patients with CKD: European Best Practice recommendations Francesco Locatelli, Lecco, Italy
08.00–09.30
• Tubular transport – Calcium in motion: from renal transporters to new concepts René Bindels, Nijmegen, The Netherlands – Distal tubular potassium channels and renal salt wasting Richard Warth, Regensburg, Germany – The epithelial sodium channel (ENaC) and its role in arterial hypertension and renal sodium retention Cristoph Korbmacher, Erlangen, Germany – Amino acid transport François Verrey, Zürich, Switzerland
11.30–12.30
• Endothelin and endothelin-receptor antagonists – Pathophysiology of the endothelin system: lessons from genetically manipulated animals models Berthold Hocher, Berlin, Germany – Endothelin-1 and its antagonism in chronic kidney disease Neeraj Dhaun, Edinburgh, UK – Endothelin receptor antagonists in diabetic nephropathy René R. Wenzel, Zell am See, Austria
Downloaded from http://ckj.oxfordjournals.org/ at Oakland University on June 9, 2015
08.00–09.30
Scientific Programme
Sunday, June 27th, 2010
• The bone and CKD – The culprit of osteoporosis in CKD Marie-Hélène Lafage-Proust, Saint-Etienne, France – Calcium metabolism changes after transplantation Pieter Evenepoel, Leuven, Belgium – Adynamic bone disease: from bone to vessels Jordi Bover, Barcelona, Spain
11.30–12.30
• Nephroprotection – Screening for albuminuria in the prevention of renal function loss Ronald T. Gansevoort, Groningen, Netherlands – RAAS blockade in native and grafted kidneys P. Rutkowski, Gdansk, Poland – Pleiotropic effects of ATR1 blockers Giuseppe Remuzzi, Bergamo, Italy
11.30–12.30
• Regulatory aspects of kidney function – (Patho)physiology of intercalated cells Carsten Wagner, Zürich, Switzerland – The serum and glucocorticoid inducible kinase SGK1 in the regulation of renal function and blood pressure Florian Lang, Tübingen, Germany – Impact of trans- and paracellular permeability Markus Bleich, Kiel, Germany
Literature Updates Saturday, June 26th, 2010 17.00–18.30
• Clinical nephrology – Optimal management of hypertension Giuseppe Mancia, Milan, Italy – Side effects in treatment in nephrology David Jayne, Cambridge, UK – Current and future therapy of glomerular diseases Alan Salama, London, UK
17.00–18.30
• Transplantation – What should we be doing about renal preservation? N. Mamode, London, UK – Immunosuppression Uwe Heemann, Munich, Germany – Polyomavirus infection in renal transplantation Cristina Costa, Turin, Italy – Recurrent renal diseases Pierre Cochat, Lyon, France
Sunday, June 27th, 2010 16.45–18.15
• Dialysis – Fluid balance and core temperature control to improve hemodynamic stability Karel Leunissen, Maastricht, Netherlands – Diffusive and convective toxin removal by dialysis procedures Detlef Krieter, Würzburg, Germany – Vaccination and hygiene strategies for infection prevention Michel Jadoul, Louvain, Belgium – Oxidative stress in dialysis patients: causes and consequences Jan Kielstein, Hannover, Germany
Downloaded from http://ckj.oxfordjournals.org/ at Oakland University on June 9, 2015
11.30–12.30
XXIX
XXX
Sunday, June 27th, 2010
Scientific Programme
Compact Primers Sunday, June 27th, 2010 • Treatment of AKI in special populations – Renal transplantation Christophe Legendre, Paris, France – AKI in children Franz Schaefer, Heidelberg, Germany – AKI in HIV-infected patients Paul L. Kimmel, Bethesda, USA – Treatment of AKI in oncology patients Claudio Ronco, Vicenza, Italy
14.30–16.00
• Practices in renal transplantation – Cardiovascular screening of potential transplant recipients Alan G. Jardine, Glasgow, UK – Sense or non sense of screening transplant recipients for malignancies Bryce Kiberd, Halifax, Canada – Pregnancy in transplant donors Anna Varberg Reisaeter, Oslo, Norway – Donor registries: the common Living Donor Database within Scandinavia Ole Oyen, Oslo, Norway
Monday, June 28th, 2010 11.30–12.30
• Peritoneal dialysis in special patients – Volume in PD: the heart of the matter Wim van Biesen, Ghent, Belgium – Peritoneal dialysis in cirrhotic patients: effects on portal hypertension Rafael Selgas, Madrid, Spain – Optimal use of peritoneal dialyis in diabetic patients Francisco Coronel, Madrid, Spain
Pre-Congress CME Courses Friday, June 25th, 2010 08.00–12.30
13.00–17.30
• Animal models of renal diseases • Transplant immunology • Renal ultrasonography • Omics in nephrology • Rheumatology for nephrologists
Sunday, June 27th, 2010 16.45–18.15
• Rare renal diseases
Late Breaking Trials Saturday, June 26th, 2010 08.00–09.30
• Late breaking trials 1
Sunday, June 27th, 2010 14.30–16.00
• Late breaking trials 2
Downloaded from http://ckj.oxfordjournals.org/ at Oakland University on June 9, 2015
08.00–09.30
